Target intelligence / Profile preview

Rho guanine nucleotide exchange factor 10-like protein (ARHGEF10L)

Target
ARHGEF10L
Molecular classification
Guanine nucleotide exchange factor, Signal transduction protein, RhoGEF subfamily
01

Overview

Rho guanine nucleotide exchange factor 10-like protein (ARHGEF10L) is a guanine nucleotide exchange factor (GEF) belonging to the RhoGEF subfamily. It specifically activates Rho GTPases such as RhoA, RHOB, and RHOC, which are pivotal regulators of the cytoskeleton, cell migration, and many aspects of cell signaling. ARHGEF10L promotes cancer cell proliferation, migration, and epithelial-to-mesenchymal transition via the RhoA–ROCK1–phospho-ERM pathway and is overexpressed in a variety of malignancies, including cervical, liver, and gastric cancers. It is associated with increased tumor aggressiveness and risk, making it a candidate oncogene and a potential molecular marker in tumor biology. The gene has also been implicated in non-cancerous diseases such as cerebral visual impairment. Its functional domains include a Dbl homology domain and a WD40-like domain, and it is mostly cytosolic in distribution[1][2][3].

Other names
Rho guanine nucleotide exchange factor 10-likeARHGEF10LGrinchGEFKIAA1626FLJ10521rho guanine nucleotide exchange factor (GEF) 10-like
02

Mechanism of action

Activation of RhoA, RHOB, RHOC (small GTPases) via guanine nucleotide exchange; Promotion of RhoA–ROCK1–phospho-ERM signaling pathway; Induction of EMT markers (e.g., N-cadherin, Slug) and downregulation of epithelial markers (e.g., E-cadherin)

03

Biological functions

Signal transductionCell proliferationCell migrationEpithelial-to-mesenchymal transition (EMT)Apoptosis regulationCytoskeletal remodeling
04

Disease associations

Cancer (carcinogenesis in cervical, liver, gastric, basal cell carcinoma, ovarian cancer, osteosarcoma)Other (implicated in cerebral visual impairment)
05

Safety considerations

Potential for promoting tumorigenesis, migration, and metastasis if targeted non-selectivelyUnknown safety profile for drug targeting; likely risk in cancer contexts due to oncogenic roles
06

Biomarkers

Increased expression of ARHGEF10L (as an oncogenic marker in some cancers)HSPA6 upregulation (downstream marker in specific cancer contexts)

Beyond the preview

Go deeper on Rho guanine nucleotide exchange factor 10-like protein (ARHGEF10L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho guanine nucleotide exchange factor 10-like protein (ARHGEF10L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call